Caldan Therapeutics
This profile has not been verified by the business owner.
Information may be incomplete or outdated.
Overview
Caldan, a spin-out company from the Universities of Glasgow and Southern Denmark, is developing
novel therapeutics targeting free fatty acid receptors for NASH, Type 2 Diabetes (T2D) and other potential indications. Caldan has arisen from a long-term collaboration between Professor Trond Ulven at the University of Southern Denmark and Professor Graeme Milligan of the University of Glasgow.
Contact Details
info@caldantherapeutics.co.uk
Edinburgh, United Kingdom (UK)
Founded
2015
Employees
2-10
Categories
Keywords
You're invisible in searches for:
Add keywords that describe your company, services, or market to improve your visibility in search results.
Companies teams usually look at after Caldan Therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.